Ng George K
CIK 0001638744
Chief Executive OfficerDirector
Filings
20
Latest Jun 1, 2026
Issuers covered
2
Showing
20 of 20
Page 1
Track record
8 of 10 open-market trades scored (80% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 25% | -1.4% | 0.0% | +6.9% | -10.6% |
| 90 days | 2 | 0% | -41.9% | -41.9% | -22.2% | -61.6% |
| 180 days | 2 | 0% | -49.6% | -49.6% | -37.0% | -62.1% |
| 365 days | 2 | 0% | -78.6% | -78.6% | -78.1% | -79.2% |
Issuers
Companies where Ng George K has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | 17 | Jun 1, 2026 |
| KTRA | Kintara Therapeutics, Inc. | 3 | Feb 17, 2026 |
All filings
20 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|